Multiple Sclerosis Auckland Research Day 2016: Dr Travis Stiles (full presentation)

Dr Travis Stiles (CEO, Novoron Bioscience) presented at the Multiple Sclerosis Auckland Research Day 2016 to discuss remyelination and the drug design process. Travis' presentation included a background into why myelin repair doesn't occur in people with MS and how Novoron's novel therapy targets this process to promote remyelination. Travis also spoke at length about how the drug development pathway has changed over the past decade and how important it is for the MS community to be engaged and informed to ensure the best possible research outcomes.